Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis.

Johan H JendleÅsa EricssonJens GundgaardJonas Bech MøllerWilliam J ValentineBarnaby Hunt

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

Use of smart insulin pens was projected to improve clinical outcomes at lower costs relative to standard care in a Swedish T1D population and represents a good use of healthcare resources in Sweden.

Keyphrases

healthcare
type diabetes
palliative care
quality improvement
glycemic control
affordable care act
climate change
smoking cessation